Skip to main content

Advertisement

Log in

Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Objective

Male hypogonadism is common in the elderly and has been associated with increased risk of mortality. Our objective has been to assess the prevalence of primary and central hypogonadism in elderly male patients admitted to the hospital because of acute illness. We also evaluated the relationships between gonadal dysfunction and in-hospital mortality.

Patients and methods

150 patients, aged ≥65 years, admitted during 2010 and 2011 in our geriatric unit, were studied. Serum concentrations total, bioavailable and free testosterone, as well as of follicle-stimulating hormone and luteinizing hormone were quantified in every patient. Hypogonadism was defined by the presence of serum testosterone levels lower than 200 ng/dl.

Results

Hypogonadism was found in 80 patients (53.3 %). Serum gonadotropin concentrations were elevated in 43.7 % of these patients, whereas 41.3 % of hypogonadic patients showed normal and 15 % low gonadotropin concentrations. Respiratory tract infection and congestive heart failure were the main causes of hospitalization in hypogonadal men, whereas acute cerebrovascular disease was the main reason for admission in eugonadal patients. Of the 13 patients who died during hospitalization, 12 were hypogonadic. Patients who died showed significantly lower serum levels of total, free and bioavailable testosterone than those found in patients who survived.

Conclusion

Our results show that about half of patients admitted for acute illness have hypogonadism, mainly of non-hypergonadotropic type. Gonadal hypofunction is significantly related with in-hospital mortality. A low value of serum testosterone may be a predictor for mortality in elderly male patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tostain JL, Blanc F (2008) Testosterone deficiency: a common, unrecognized syndrome. Nat Clin Pract Urol 5:388–396

    Article  CAS  PubMed  Google Scholar 

  2. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore longitudinal study of aging. J Clin Endocrinol Metab 86:724–731

    Article  CAS  PubMed  Google Scholar 

  3. Vermeulen A, Kaufman JM (2002) Diagnosis of hypogonadism in the aging male. Aging Male 5:170–176

    Article  CAS  PubMed  Google Scholar 

  4. Allan CA, McLachlan RI (2004) Age-related changes in testosterone and the role of replacement therapy in older men. Clin Endocrinol (Oxf) 60:653–670

    Article  CAS  Google Scholar 

  5. Araujo AB, O’Donnell AB, Brambilla DJ et al (2004) Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts male aging study. J Clin Endocrinol Metab 89:5920–5926

    Article  CAS  PubMed  Google Scholar 

  6. Araujo AB, Esche GR, Kupelian V et al (2007) Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab 92:4241–4247

    Article  CAS  PubMed  Google Scholar 

  7. Wang C, Nieschlag E, Swerdloff R et al (2008) Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol 159:507–514

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Wu FC, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. J Clin Endocrinol Metab 93:2737–2745

    Article  CAS  PubMed  Google Scholar 

  9. Venkat K, Desai M, Arora MM, Singh P, Khatkhatay MI (2009) Age-related changes in sex steroid levels influence bone mineral density in healthy Indian men. Osteoporos Int 20:955–962

    Article  CAS  PubMed  Google Scholar 

  10. Matsumoto AM (2002) Andropause: clinical implications of the decline in serum testosterone levels with aging in men. J Gerontol A Biol Sci Med Sci 57:M76–M99

    Article  PubMed  Google Scholar 

  11. Travison TG, Araujo AB, Kupelian V, O’Donnell AB, McKinlay JB (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92:549–555

    Article  CAS  PubMed  Google Scholar 

  12. Yeap BB (2010) Androgens and cardiovascular disease. Curr Opin Endocrinol Diabetes Obes 17:269–276

    Article  CAS  PubMed  Google Scholar 

  13. Tirabassi G, Gioia A, Giovannini L et al (2013) Testosterone and cardiovascular risk. Intern Emerg Med 8(Suppl 1):S65–S69

    Article  PubMed  Google Scholar 

  14. Araujo AB, Kupelian V, Page ST, Handelsman DJ, Bremner WJ, McKinlay JB (2007) Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med 167:1252–1260

    Article  CAS  PubMed  Google Scholar 

  15. Cummings-Vaughn LA, Malmstrom TK, Morley JE, Miller DK (2011) Testosterone is not associated with mortality in older African–American males. Aging Male 14:132–140

    Article  CAS  PubMed  Google Scholar 

  16. Haring R, Teng Z, Xanthakis V et al (2013) Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham heart study. Clin Endocrinol (Oxf) 78:629–634

    Article  CAS  Google Scholar 

  17. Lehtonen A, Huupponen R, Tuomilehto J et al (2008) Serum testosterone but not leptin predicts mortality in elderly men. Age Ageing 37:461–464

    Article  PubMed  Google Scholar 

  18. Tivesten A, Vandenput L, Labrie F et al (2009) Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 94:2482–2488

    Article  CAS  PubMed  Google Scholar 

  19. Corona G, Rastrelli G, Monami M et al (2011) Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study. Eur J Endocrinol 165:687–701

    Article  CAS  PubMed  Google Scholar 

  20. Shah S, Vanclay F, Cooper B (1989) Improving the sensitivity of the Barthel Index for stroke rehabilitation. J Clin Epidemiol 42:703–709

    Article  CAS  PubMed  Google Scholar 

  21. Vermeulen A, Verdonck L, Kaufman JM (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666–3672

    Article  CAS  PubMed  Google Scholar 

  22. Kalyani RR, Gavini S, Dobs AS (2007) Male hypogonadism in systemic disease. Endocrinol Metab Clin N Am 36:333–348

    Article  CAS  Google Scholar 

  23. Veldhuis JD, Keenan DM, Liu PY, Iranmanesh A, Takahashi PY, Nehra AX (2009) The aging male hypothalamic-pituitary-gonadal axis: pulsatility and feedback. Mol Cell Endocrinol 299:14–22

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Karadag F, Ozcan H, Karul AB, Yilmaz M, Cildag O (2009) Sex hormone alterations and systemic inflammation in chronic obstructive pulmonary disease. Int J Clin Pract 63:275–281

    Article  CAS  PubMed  Google Scholar 

  25. Yeap BB, Hyde Z, Almeida OP et al (2009) Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab 94:2353–2359

    Article  CAS  PubMed  Google Scholar 

  26. Khaw KT, Dowsett M, Folkerd E et al (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) prospective population study. Circulation 116:2694–2701

    Article  CAS  PubMed  Google Scholar 

  27. Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68–75

    Article  CAS  PubMed  Google Scholar 

  28. Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM (2012) Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab 97:2050–2058

    Article  CAS  PubMed  Google Scholar 

  29. Iglesias P, Muñoz A, Prado F et al (2009) Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin Endocrinol (Oxf) 70:961–967

    Article  CAS  Google Scholar 

  30. Iglesias P, Polini A, Muñoz A et al (2011) Fasting hyperglycaemia and in-hospital mortality in elderly population. Int J Clin Pract 65:308–313

    Article  CAS  PubMed  Google Scholar 

  31. Corona G, Rastrelli G, Monami M et al (2011) Body mass index regulates hypogonadism-associated CV risk: results from a cohort of subjects with erectile dysfunction. J Sex Med 8:2098–2105

    Article  PubMed  Google Scholar 

Download references

Funding

Junta de Castilla y León (Spain), Consejería de Sanidad, Proyectos de Investigación en Biomedicina, Biotecnología y Ciencias de la Salud. Expediente n° GRS 393/A/09.

Conflict of interest

The authors P. Iglesias, F. Prado, M.C. Macías, M.T. Guerrero, A. Muñoz, E. Ridruejo, P. Tajada, C. García-Arévalo, and J.J. Díez declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Iglesias.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iglesias, P., Prado, F., Macías, M.C. et al. Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome. J Endocrinol Invest 37, 135–141 (2014). https://doi.org/10.1007/s40618-013-0009-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-013-0009-x

Keywords

Navigation